Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Fuji
Federal Trade Commission
Baxter
Covington
QuintilesIMS
Medtronic
Cerilliant
Moodys
Chinese Patent Office

Generated: October 21, 2017

DrugPatentWatch Database Preview

Nexgen Pharma Inc Company Profile

« Back to Dashboard

What is the competitive landscape for NEXGEN PHARMA INC, and what generic and branded alternatives to NEXGEN PHARMA INC drugs are available?

NEXGEN PHARMA INC has fifteen approved drugs.



Summary for Applicant: Nexgen Pharma Inc

US Patents:0
Tradenames:14
Ingredients:14
NDAs:15
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nexgen Pharma Inc
MEPROBAMATE
meprobamate
TABLET;ORAL084220-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Nexgen Pharma Inc
FOLIC ACID
folic acid
TABLET;ORAL084915-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Nexgen Pharma Inc
DIPHENHYDRAMINE HYDROCHLORIDE
diphenhydramine hydrochloride
CAPSULE;ORAL083634-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Nexgen Pharma Inc
MEPROBAMATE
meprobamate
TABLET;ORAL084589-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Nexgen Pharma Inc
SODIUM PENTOBARBITAL
pentobarbital sodium
TABLET;ORAL084238-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Nexgen Pharma Inc
POLYETHYLENE GLYCOL 3350
polyethylene glycol 3350
FOR SOLUTION;ORAL077706-001Sep 27, 2006AARXNoNo► Subscribe► Subscribe► Subscribe
Nexgen Pharma Inc
ISONIAZID
isoniazid
TABLET;ORAL084050-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Nexgen Pharma Inc
BROMPHENIRAMINE MALEATE
brompheniramine maleate
TABLET;ORAL086187-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Nexgen Pharma Inc
HYDROCORTISONE
hydrocortisone
TABLET;ORAL083140-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Nexgen Pharma Inc
DIMENHYDRINATE
dimenhydrinate
TABLET;ORAL085985-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Mallinckrodt
QuintilesIMS
Chubb
Express Scripts
UBS
Dow
Harvard Business School
Colorcon
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot